These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9384712)

  • 21. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
    Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular biological pathophysiology of chronic myelogenous leukemia].
    Nishimura J
    Fukuoka Igaku Zasshi; 1995 Feb; 86(2):19-23. PubMed ID: 7729779
    [No Abstract]   [Full Text] [Related]  

  • 23. Abl: the prototype of oncogenic fusion proteins.
    Saglio G; Cilloni D
    Cell Mol Life Sci; 2004 Dec; 61(23):2897-911. PubMed ID: 15583852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Important therapeutic targets in chronic myelogenous leukemia.
    Kantarjian HM; Giles F; Quintás-Cardama A; Cortes J
    Clin Cancer Res; 2007 Feb; 13(4):1089-97. PubMed ID: 17317816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms of transformation by the BCR-ABL oncogene.
    Sattler M; Griffin JD
    Semin Hematol; 2003 Apr; 40(2 Suppl 2):4-10. PubMed ID: 12783368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S; Luthra R; Cano P
    BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
    Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
    Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
    Ren SY; Xue F; Feng J; Skorski T
    Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia.
    Kabarowski JH; Witte ON
    Stem Cells; 2000; 18(6):399-408. PubMed ID: 11072027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Philadelphia translocation in CML and ALL: recent investigations, new detection methods.
    Hagemeijer A; van der Plas DC; Soekarman D; van Denderen J; Grosveld G
    Nouv Rev Fr Hematol (1978); 1990; 32(1):83-6. PubMed ID: 2190182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Klco JM; Kreisel FH; Zehnbauer BA; Kulkarni S; Hassan A; Frater JL
    Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of BCR-ABL gene sequences using RT-PCR in patients with leukemia in the IX region. Chile].
    Artigas CG; Melo A; Roa JC; Páez E; Vittini C; Arriagada M; González L; Pflaumer E; Roa I
    Rev Med Chil; 2002 Jun; 130(6):623-30. PubMed ID: 12194684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bcr-abl translocation: diagnostic methods and clinical value].
    Pignon JM
    Ann Biol Clin (Paris); 1998; 56(1):57-63. PubMed ID: 9754223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular detection of the BCR-ABL gen by RT-PCR in Costa Rican children with leukemia].
    Jiménez-Arce G; Carrillo J; Chaves M; Jiménez R; Vargas M; Campos L; de la Guardia A; Valverde B
    Rev Biol Trop; 2008 Dec; 56(4):1613-8. PubMed ID: 19419069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular biology of CML: a review.
    Leibowitz D; Young KS
    Cancer Invest; 1989; 7(2):195-203. PubMed ID: 2676087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model.
    Ren R
    Oncogene; 2002 Dec; 21(56):8629-42. PubMed ID: 12476309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
    Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
    Ren R
    Nat Rev Cancer; 2005 Mar; 5(3):172-83. PubMed ID: 15719031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.